tiprankstipranks
Advertisement
Advertisement
Nanobiotix Raises Approximately $100 Million After Full Exercise of Over-Allotment Option
PremiumCompany AnnouncementsNanobiotix Raises Approximately $100 Million After Full Exercise of Over-Allotment Option
19d ago
Premium
Ratings
Nanobiotix Reaffirmed at Buy on Strengthened Balance Sheet and Strategic Shift Toward Nanoprimer Platform Growth
20d ago
Nanobiotix falls -9.0%
Premium
The Fly
Nanobiotix falls -9.0%
21d ago
Nanobiotix Reports Early Positive Phase 2 CONVERGE Data in Stage 3 NSCLC
PremiumCompany AnnouncementsNanobiotix Reports Early Positive Phase 2 CONVERGE Data in Stage 3 NSCLC
21d ago
Nanobiotix announces EUR 75M global follow-on offering
Premium
The Fly
Nanobiotix announces EUR 75M global follow-on offering
21d ago
Nanobiotix files EUR75M ordinary shares offering
Premium
The Fly
Nanobiotix files EUR75M ordinary shares offering
22d ago
Nanobiotix price target raised to $30 from $3.50 at UBS
PremiumThe FlyNanobiotix price target raised to $30 from $3.50 at UBS
1M ago
Premium
Ratings
Nanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy Rating
2M ago
Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer Immunotherapy
Premium
Company Announcements
Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer Immunotherapy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100